Connection
Joseph Saseen to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Joseph Saseen has written about Dose-Response Relationship, Drug.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.166 |
|
|
|
-
Saseen JJ, Ghushchyan V, Nair KV. Comparing clinical effectiveness and drug toxicity with hydrochlorothiazide and chlorthalidone using two potency ratios in a managed care population. J Clin Hypertens (Greenwich). 2015 Feb; 17(2):134-40.
Score: 0.085
-
Sontheimer D, Hitchcock K, Saseen J. Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension? J Fam Pract. 2007 Apr; 56(4):312-4.
Score: 0.050
-
Alford JC, Saseen JJ, Allen RR, Nair KV. Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions. Pharmacotherapy. 2012 Jul; 32(7):623-30.
Score: 0.018
-
Nair KV, Tang B, Van Den Bos J, Zhang V, Saseen JJ, Naim A, Rahman M. Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations. Curr Med Res Opin. 2009 Feb; 25(2):303-14.
Score: 0.014